Competing Heterogeneities in Vaccine Effectiveness Estimation
Understanding waning of vaccine-induced protection is important for both immunology and public health. Population heterogeneities in underlying (pre-vaccination) susceptibility and vaccine response can cause measured vaccine effectiveness (mVE) to change over time even in the absence of pathogen evolution and any actual waning of immune responses. We use a multi-scale agent-based models parameterized using epidemiological and immunological data, to investigate the effect of these heterogeneities on mVE as measured by the hazard ratio. Based on our previous work, we consider waning of antibodies according to a power law and link it to protection in two ways: 1) motivated by correlates of risk data and 2) using a within-host model of stochastic viral extinction. The effect of the heterogeneities is given by concise and understandable formulas, one of which is essentially a generalization of Fisher's fundamental theorem of natural selection to include higher derivatives. Heterogeneity in underlying susceptibility accelerates apparent waning, whereas heterogeneity in vaccine response slows down apparent waning. Our models suggest that heterogeneity in underlying susceptibility is likely to dominate. However, heterogeneity in vaccine response offsets <10% to >100% (median of 29%) of this effect in our simulations. Our methodology and results may be helpful in understanding competing heterogeneities and waning of immunity and vaccine-induced protection. Our study suggests heterogeneity is more likely to 'bias' mVE downwards towards faster waning of immunity but a subtle bias in the opposite direction is also plausible.
Code (0)
등록된 구현이 없습니다.
Similar Papers 제목 키워드 기반
Using a physical model and aggregate data to estimate the spreading of Covid-19 in Israel in the presence of waning immunity and competing variants
In more than two years since the COVID-19 virus was first detected in China, hundreds of millions of individuals have been infected, and millions have died. Aside from the immediate need for medical solutions (such as va…
Estimating Waning of Vaccine Effectiveness: a Simulation Study
Developing accurate and reliable methods to estimate vaccine protection is a key goal in immunology and public health. While several statistical methods have been proposed, their potential inaccuracy in capturing fast in…
Prediction of Influenza B Vaccine Effectiveness from Sequence Data
Influenza is a contagious respiratory illness that causes significant human morbidity and mortality, affecting 5-15% of the population in a typical epidemic season. Human influenza epidemics are caused by types A and B, …
Targeted maximum likelihood estimation of vaccine effectiveness and immune correlates in test-negative design studies with missing data
The test-negative design (TND) is a resource-efficient observational study design that can assess vaccine effectiveness and exposure-proximal immune correlates of disease. The TND enrolls symptomatic individuals seeking …
Causal InferenceTackling Intertwined Data and Device Heterogeneities in Federated Learning with Unlimited Staleness
Federated Learning (FL) can be affected by data and device heterogeneities, caused by clients' different local data distributions and latencies in uploading model updates (i.e., staleness). Traditional schemes consider t…
Computational EfficiencyFederated Learning